Arcadia Biosciences
RKDA
13 hedge funds and large institutions have $77.4K invested in Arcadia Biosciences in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 3 closing their positions.
1.94% less ownership
Funds ownership: 4.79% → 2.85% (-1.9%)
19% less funds holding
Funds holding: 16 → 13 (-3)
66% less capital invested
Capital invested by funds: $227K → $77.4K (-$150K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 6
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
-$42.6K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
-$34.8K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$8.64K |
| 4 |
Morgan Stanley
New York
|
-$2.23K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.97K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $27.8K | – | – | – |
|
2
State Street
Boston,
Massachusetts
| $24K | – | – | – |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $21.1K | -$8.64K | -2,346 | -18% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $2.92K | -$777 | -211 | -13% |
|
|
5
UBS Group
Zurich,
Switzerland
| $1.12K | -$1.97K | -534 | -49% |
|
|
SS
6
SBI Securities
Tokyo,
Japan
| $238 | -$7 | -2 | -2% |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $148 | – | – | – |
|
8
Group One Trading
Chicago,
Illinois
| $36 | – | – | – |
|
9
Bank of America
Charlotte,
North Carolina
| $24 | – | – | – |
|
10
AssetMark Inc
Concord,
California
| $10 | – | – | – |
|
|
11
Morgan Stanley
New York
| $4 | -$2.23K | -606 | -100% |
|
12
Citigroup
New York
| $2 | -$1.31K | -355 | -100% |
|
|
HI
13
Harbour Investments
Madison,
Wisconsin
| $2 | – | – | – |
|
|
14
Mariner
Overland Park,
Kansas
| – | -$42.6K | -12,264 | Closed |
|
|
DS
15
DRW Securities
Chicago,
Illinois
| – | -$34.8K | -10,032 | Closed |
|
|
PP
16
PFS Partners
Mine Hill,
New Jersey
| – | -$18 | -5 | Closed |
|
RKDA Hedge Fund Activity: Q4 2025 in Review
13 of the 8,226 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2025, worth a combined $77.4K — down 66% from $227K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of RKDA and 0 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 0 added.
The largest seller was Mariner, exiting entirely with an estimated $42.6K sold.
- 13 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2025, down from 16 in Q3 2025.
- Funds reported $77.4K of Arcadia Biosciences stock for Q4 2025, down 66% quarter-over-quarter.
- 0 funds opened new Arcadia Biosciences positions in Q4 2025 and 3 closed out, a net change of -3 holders.
- The largest Arcadia Biosciences seller in Q4 2025 was Mariner, an estimated $42.6K sold.
Based on aggregated 13F filings for Q4 2025.